MarketCap
Facebook
X
TelegramGeschäftsbericht 2021
hinzugefügt 23.12.2023
Zealand Pharma A/S EV 2011-2026 | ZEAL
EV Jährlich Zealand Pharma A/S
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 866 M | 650 M | 569 M | -306 M | 673 M | 416 M | 382 M | 344 M | 30.8 M | 30 M | 28.1 M |
Alle Zahlen in DKK-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 866 M | -306 M | 335 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
Adagene
ADAG
|
395 M | $ 1.68 | 1.9 % | $ 94.6 M |  China |
 |
Aptorum Group Limited
APM
|
9.45 M | $ 1.08 | -0.19 % | $ 5.89 M | China |
 |
Arrowhead Pharmaceuticals
ARWR
|
6.02 B | $ 65.3 | 0.46 % | $ 8.73 B |  USA |
 |
Ascendis Pharma A/S
ASND
|
726 M | $ 210.55 | 0.86 % | $ 5 B |  Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.41 | 2.4 % | $ 8.2 B |  Australia |
 |
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | USA |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M |  France |
 |
Autolus Therapeutics plc
AUTL
|
1.11 B | $ 1.86 | -2.62 % | $ 475 M |  Britain |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | USA |
 |
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | Britain |
 |
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
5.65 B | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | USA |
 |
Biogen
BIIB
|
28.3 B | $ 187.47 | 0.79 % | $ 27.3 B | USA |
 |
Avenue Therapeutics
ATXI
|
-1.23 M | - | -52.27 % | $ 4.45 M | USA |
 |
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
BioVie
BIVI
|
-12.6 M | $ 1.29 | -0.77 % | $ 1.91 M | USA |
 |
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
-6.64 B | $ 100.15 | 1.31 % | $ 27.2 B | Germany |
 |
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
2 B | $ 27.62 | -0.43 % | $ 1.34 B | USA |
 |
BioXcel Therapeutics
BTAI
|
107 M | $ 1.98 | -1.0 % | $ 5.02 M | USA |
 |
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
10.2 B | $ 11.85 | 4.45 % | $ 766 M | USA |
 |
BioDelivery Sciences International
BDSI
|
445 M | - | -4.8 % | $ 255 M | USA |
 |
Axon Enterprise
AXON
|
41.5 B | $ 629.67 | 2.72 % | $ 47.7 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M |  Israel |
 |
Aytu BioScience
AYTU
|
-15.2 M | $ 2.65 | -0.38 % | $ 16.6 M | USA |
 |
BeiGene, Ltd.
BGNE
|
253 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
AstraZeneca PLC
AZN
|
57.7 B | $ 95.16 | 1.22 % | $ 96.9 B | Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | USA |
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 4.17 | -3.02 % | $ 9.07 B | Israel |
 |
Burford Capital Limited
BUR
|
3.22 B | $ 9.34 | 0.59 % | $ 1.52 B | Britain |
 |
Catalyst Biosciences
CBIO
|
38.1 M | $ 10.92 | -0.46 % | $ 719 M | USA |
 |
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | USA |